DocGo Inc Dossier
Qualitative Analysis
Business overview
DocGo Inc. (Nasdaq: DCGO) is a leading provider of technology-enabled mobile health and medical transportation services in the United States and the United Kingdom. The company operates through two primary segments: Mobile Health Services and Transportation Services. DocGo's care delivery platform brings physical, in-person clinical care directly to patients' homes, offices, and community locations, bridging the gap between traditional telehealth and physical medical visits. Its services include mobile urgent care, remote patient monitoring, chronic disease management, and emergency/non-emergency medical transportation. DocGo serves a diverse client base comprising municipalities, hospital systems, health plans, and corporate employers.
Research as of 19 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Participating in the CMS Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Model across three tracks: early cardio-kidney-metabolic (eCKM), cardio-kidney-metabolic (CKM), and musculoskeletal (MSK) conditions.
Expected impact: Provides stable, recurring, outcome-aligned Medicare payments for technology-supported chronic care management.
Integrating SteadyMD's 50-state virtual clinician network with DocGo's physical mobile health clinicians to optimize care delivery and improve gross margins.
Expected impact: Expected to drive over 50% top-line growth at SteadyMD in 2026 and potentially improve gross margins by up to 10% through efficient telehealth provider utilization.
Scaling mobile phlebotomy and lab collection services across South Florida, Upstate New York, Pennsylvania, and other key markets.
Expected impact: Projected to accelerate mobile phlebotomy growth to as much as 75% in 2026, serving as a high-margin contributor to Mobile Health Services.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
To combine SteadyMD's nationwide virtual clinician workforce and 50-state telehealth platform with DocGo's last-mile mobile health services, creating a comprehensive physical-virtual care delivery platform.
Financial impact: Expected to generate approximately $25 million in revenue in 2025 and to achieve positive EBITDA by 2026.
To expand DocGo's healthcare service offerings to include mobile phlebotomy lab collection and diagnostic services, leveraging PTI's integrations with the nation's two largest laboratory providers.
Financial impact: Serves as the foundation for the mobile phlebotomy business, which is projected to grow up to 75% in 2026.
Strategic Partnerships
Bridges healthcare gaps by delivering proactive, in-home preventative care services (annual wellness visits, retinal exams, bone density tests) to thousands of patients, supporting a cost-reducing value-based model.
Terms: Not disclosed